RenovaCare Announces Successful FDA Meeting
RenovaCare (RCAR) announces positive outcomes from its pre-submission meeting with the United States Food and Drug Administration (FDA) regarding the RenovaCare SkinGun™ and CellMist™ Systems.
RenovaCare (RCAR) announces positive outcomes from its pre-submission meeting with the United States Food and Drug Administration (FDA) regarding the RenovaCare SkinGun™ and CellMist™ Systems.